-
The market continues to expand, and pharmaceutical companies are accelerating their entry into the CRO field
Time of Update: 2022-11-25
It is understood that in recent years, in the context of the continuous deepening of domestic medical reform, the consistency evaluation of generic drugs has opened the market access and reshuffle of existing pharmaceutical products, and the priority review and approval, drug marketing authorization holder system greatly encourages the innovation and upgrading of the entire industry and the professional division of labor, the CRO industry is ushering in huge development opportunities.
-
"Silent killer" – COVID-19 has been shown to trigger inflammation in the brain
Time of Update: 2022-11-04
The University of Queensland research team was led by Professor Trent Woodruff and Dr Eduardo Albornoz Balmaceda from the University of Queensland's School of Biomedical Sciences and virologists from the School of Chemical and Molecular Biosciences.
-
Will new conjugate drugs also give birth to "DS-8201"? A number of candidate products are beginning to appear therapeutic
Time of Update: 2022-09-15
Antibody drug group to understand the industry's cutting-edge information to obtain dry goods information and industry big coffee in-depth discussion to identify the following two-dimensional code, you can enter the groupIf the group QR code expires, please add the xiaobian QR code on the right side to enter the groupFPI-1966 is based on Fusion's TAT platform, which connects α particles to a monoclonal antibody vofatamab via a unique Fast-Clear™ linker, enabling the delivery of radioactive materials to tumor cells.
-
2021 China's top ten progress in life science announced that artificial synthetic starch was selected
Time of Update: 2022-09-03
January 10, China Association for Science and Technology Life Science The consortium of societies announced the results of the 2021 "Top Ten Progresses in China's Life Sciences", and 8 knowledge innovation and 2 technological innovation projects were selected .
-
[Latest] Inventory of innovative drugs on the market: it is time to forge ahead
Time of Update: 2022-08-15
In 2021, China's innovative drug industry has been advancing rapidly, the number of approvals for marketing has reached a new high, the coverage of therapeutic areas has been further expanded, a number of innovative traditional Chinese medicine drugs have been approved for marketing, and independent research and development has achieved remarkable results .
-
List of 29 recommended points in "China Guidelines for the Diagnosis and Treatment of Acute Pancreatitis (2021
Time of Update: 2022-05-29
(Evidence level: moderate; strength of recommendation: strong) Recommendation 3: For patients with suspected biliary acute pancreatitis, routine ultrasonography should be performed at the time of admission or at the early stage of the disease to confirm the presence of biliary stones .
-
Cell sub-journal: 7 months after the new crown, virus residues still exist in feces
Time of Update: 2022-05-16
Med Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infectionThe study showed that even if the virus was no longer detectable in the respiratory tract, 12.
-
Promoting the healthy and orderly development of the hydrogen energy industry to help achieve the goal of peak carbon and carbon neutrality——Expert Interpretation of "Medium and Long-Term Planning
Time of Update: 2022-04-28
Hydrogen energy is rich in sources, widely used, and has green and low-carbon characteristics. It is recognized by the industry as one of the important carriers of energy transformation and developme
-
Rival or partner
Time of Update: 2022-04-28
Yervoy approvals in the US Source: Zhongkang FIC database, Zhongkang Industry Research Center Around relatlimab, BMS has conducted 10 clinical trials involving nearly 5,000 subjects .
The Phase II/III clinical trial Relativity-047 (NCT03470922) is a pivotal trial supporting the approval of Opdualag (O drug + relatlimab) for melanoma .
-
These four clinically urgently needed imported drugs have been approved for use in batches
Time of Update: 2021-12-27
It is understood that since the Hainan Provincial Food and Drug Administration approved five licensed drugs at the same time on November 26, the approval efficiency of clinically urgently needed imported drugs in the Boao Lecheng International Medical Tourism Pioneer Zone has been greatly improved .
-
Another pharmaceutical company has entered the battle for over 15 billion yuan in the contrast agent market
Time of Update: 2021-09-30
In addition, in February of this year, Chengdu Better Pharmaceuticals also issued an announcement stating that its application for imitation listing of Category 4 iopromide injection was accepted, and it became the company's first contrast agent to apply for listing .
-
Open the "black box" of glycoprotein hormone mechanism
Time of Update: 2021-09-28
" With the "blessing" of single-particle cryo-electron microscopy technology, the research team finally analyzed the structure of 3 full-length LHCGR with near-atom resolution in an activated state, including the LHCGR (wild-type) receptor structure that binds to the endogenous hormone CG ( 4.
-
Chinese scholar PNAS published a paper: New discovery of cell mitochondria helps fight many diseases
Time of Update: 2021-09-19
Zhen Yan has been seeking a better understanding of how mitochondria work for many years, and he called this new discovery the most exciting of his career .
-
Fighting resistance: the concept of new antibiotics
Time of Update: 2021-09-04
"Rolf Müller is the coordinator of the International Research Alliance for Antibiotic Discovery and Development (IRAADD) and one of about 40 international researchers who hope to jointly avoid the imminent threat of drug resistance (AMR) .
-
Building a bridge for regeneration and repair of spinal cord injury-nerve regeneration collagen scaffold transplantation for spinal cord injury long-term follow-up shows good safety
Time of Update: 2021-09-04
Based on the study before completion of the clinical, Dai Jianwu joint research team armed Medical Research Center, features, PLA General Hospital, the Fourth Medical Center, First Affiliated Hospital of Suzhou University Hospital, in 2015 Nian 1 month of first in the world to carry out nerve regeneration A clinical study of collagen scaffold transplantation in the treatment of complete spinal cord injury .
